Binding of the bactericidal/permeability increasing protein (BPI) of granulocytes to Escherichia coli promptly produces several discrete outer envelope alterations and growth arrest without major impairment of bacterial structure or biosynthetic capabilities, raising the question whether these early effects of BPI are sufficient to cause bacterial death. In this study, the bactericidal action of BPI was examined more closely. We have found that bovine or human serum albumin blocks bacterial killing without preventing BPI binding or an increase in outer membrane permeability. Moreover, addition of serum albumin after BPI results in growth resumption without displacement of bound BPI and without (early) repair of the envelope alterations. These effects are opposite to those produced by Mg2+ (80 mM), which displaces greater than 85% of bound BPI and rapidly initiates outer envelope repair without restoration of bacterial growth. The extent of rescue by serum albumin depends on the time and pH of preincubation of BPI with E. coli: e.g., for E. coli J5 treated with human BPI, t1/2 = 79 min at pH 7.4 and 10 min at pH 6.0. The serum albumin effects on BPI action are the same in wild-type E. coli and in a mutant strain lacking an activatable phospholipase, indicating that serum albumin does not act by sequestering membranedamaging products of bacterial phospholipid hydrolysis. The progression from reversible to […] 
Introduction
Binding of the bactericidal/permeability increasing protein (BPI) of granulocytes to Escherichia coli promptly produces several discrete outer envelope alterations and growth arrest without major impairment of bacterial structure or biosynthetic capabilities, raising the question whether these early effects of BPI are sufficient to cause bacterial death. In this study, the bactericidal action of BPI was examined more closely. We have found that bovine or human serum albumin blocks bacterial killing without preventing BPI binding or an increase in outer membrane permeability. Moreover, addition of serum albumin after BPI results in growth resumption without displacement of bound BPI and without (early) repair of the envelope alterations. These effects are opposite to those produced by Mg2+ (80 mM), which displaces > 85% of bound BPI and rapidly initiates outer envelope repair without restoration of bacterial growth. The extent of rescue by serum albumin depends on the time and pH of preincubation of BPI with E. coli: e.g., for E. coli J5 treated with human BPI, tl/2 = 79 min at pH 7.4 and 10 min at pH 6.0. The serum albumin effects on BPI action are the same in wild-type E. coli and in a mutant strain lacking an activatable phospholipase, indicating that serum albumin does not act by sequestering membrane-damaging products of bacterial phospholipid hydrolysis. The progression from reversible to irreversible growth arrest, revealed by the subsequent addition of serum albumin at different times, is paralleled by a decrease in amino acid uptake and an increase in the permeability of the cytoplasmic membrane to o-nitrophenyl-O-D-galactoside. These findings demonstrate at least two stages in the action of BPI: (a) an early, reversible, sublethal stage in which BPI has effects on the outer envelope and causes growth arrest, and (b) time-and pH-dependent progression to a lethal stage, apparently involving cytoplasmic membrane damage, possibly caused by penetration of a small subpopulation of BPI. (J. Clin. Invest. 1990 . 85:853-860.) bacterial inner membrane * bacterial outer membrane * bactericidal mechanisms * granulocytes -growth inhibition * serum albumin
The bactericidal/permeability increasing protein (BPI) ' is a potent cytotoxin of polymorphonuclear leukocytes that acts specifically against Gram-negative bacteria (1) (2) (3) . At lethal doses, binding of BPI to target cells is followed almost immediately by growth arrest and a number of discrete outer membrane alterations, including an increase in outer membrane permeability to normally impermeant drugs such as actinomycin D (actD) (1, (4) (5) (6) . Remarkably, bacterial growth arrest occurs despite continued macromolecular synthesis for at least 60 min, indicating that initially, BPI causes little gross functional or structural damage (1-5, 7, 8) . In fact, addition ofhigh concentrations of divalent cations (Mg2" or Ca2") or trypsin to BPI-treated bacteria removes the bulk of the bound BPI and initiates rapid (15 min) repair ofthe outer envelope damage by active biosynthesis but does not restore bacterial growth (8) (9) (10) , further demonstrating the remarkable integrity of BPItreated bacteria.
The reversibility of these outer membrane alterations suggests that the bactericidal action of BPI is mediated by other (additional) lesions on the target bacterium. The nature, sites, and timing of these effects have yet to be elucidated. The prolonged preservation of normal cellular functions despite prompt growth arrest may mean that the bactericidal action is due to an extraordinarily discrete but lethal lesion inflicted very early after binding with little or no effect on overall bacterial structure or biosynthetic capabilities. Alternately, BPI may initially cause only sublethal damage sufficient to arrest growth but killing is the consequence of later events such as BPI processing, BPI penetration, or as yet unidentified biochemical lesions.
We now show that the early consequences ofBPI treatment on target bacteria including surface binding, outer membrane alterations and growth arrest can be uncoupled from bacterial killing, indicating that the early interactions of BPI with the bacterial outer envelope are sublethal. Progression from sublethal to lethal damage is slow at neutral pH but is accelerated at pH 6.0 and is accompanied by apparently irreversible loss of cytoplasmic membrane-associated functions, suggesting that the cytoplasmic membrane is the site where BPI ultimately inflicts its lethal lesion. 
Methods

Chemicals
Purification and radiolabeling ofBPI
Human BPI and rabbit BPI were purified as previously described (1 1, 12) and stored in 50 mM sodium acetate/acetic acid buffer pH 4.0. Human BPI was labeled with '251 as described previously (1 1).
Preparation ofhuman serum
Venous blood was collected from healthy volunteers after informed consent. The serum was collected after clot formation, centrifuged at 10,000 g/20 min to remove any debris, and stored at -70'C. Heattreated serum was prepared by incubating the serum at 560C for 45 min before storage at -70'C.
Bacterial strains and growth conditions
Escherichia coli J5, a rough UDP-galactose-4-epimerase negative mutant of the smooth strain 011 1-B4, and the smooth strains E. coli ML-35 (i-, y-, z+) (a generous gift of R. Lehrer, Department of Medicine, UCLA Center for the Health Sciences, Los Angeles, CA) and E. coli 09 were grown in triethanolamine buffered (pH 7.7-7.9) minimal salts medium (13) . Other rough strains ofE. coli, PL2, 1602, and 1303, (a pldA-mutant of strain 1602 lacking the detergent-resistant phospholipase A [ 14] ), and the smooth strain E. coli 0 11 :B4 were grown in physiological saline supplemented with 0.8% (wt/vol) nutrient broth (Difco Laboratories, Detroit, MI). A clinical isolate of E. coli containing Kl capsule (a generous gift of Alan Cross, Department of Medicine, Walter Reed Hospital, Washington, DC) was grown in yeast broth (15) . Overnight cultures were transferred to fresh medium (diluted 1/10) and grown to mid-to-late logarithmic phase (-3 h) at 37°C. Bacterial concentrations were determined by absorbance at 550 nm using a Coleman Junior spectrophotometer. The bacteria were sedimented in a clinical centrifuge and resuspended to a final concentration of 1 X 109 cells per ml in sterile physiological (0.9%) saline. For amino acid uptake experiments, the cells were used immediately; for all other experiments, the cells were used within 1 h of harvesting.
Bioassays ofBPI
The standard incubation mixture contained E. coli at 4 X 107 cells/ml in sterile physiological (0.9% wt/vol) saline containing 0.8% (wt/vol) nutrient broth buffered with 20 mM NaH2PO4/Na2HPO4 at the indicated pH.
Measurement ofbacterial viability. After the indicated incubation at 37°C, aliquots of the bacteria were serially diluted 10,000-fold in sterile isotonic saline containing 4 mM MgCl2 (to prevent further BPI binding [10] ) and 400 gg/ml BSA. An aliquot (30 gl) of the diluted sample was transferred to 6 ml of 1.3% (wt/vol) molten (47°C) Bactoagar (Difco Laboratories) containing 0.8% (wt/vol) nutrient broth and 0.5% (wt/vol) NaCl and poured into a Petri dish. The agar was allowed to solidify at room temperature, and bacterial viability was measured as the number of colonies formed after incubation at 37°C for 18-24 h.
Measurement of bacterial growth. Because formation of colonies on solid nutrient agar represents growth occurring over many (18) (19) (20) (21) (22) (23) (24) hours, bacterial growth was also followed in liquid medium during the first few hours after BPI addition by measuring the optical density (550 nm) in a spectrophotometer (Model 25; Beckman Instruments, Inc., Fullerton, CA) of an aliquot of the bacterial suspension after dilution (1/10) into ice-cold isotonic saline.
Measurement of outer membrane permeability. Outer membrane permeability was measured by determining bacterial susceptibility to the normally impermeant drug actD in one of two ways: (a) Measurement of bacterial incorporation of '4C-labeled mixed amino acids into TCA precipitable material in the presence or absence of 50 ,g/ml actD as previously described (2, 3 human BPI was measured by determining the radioactivity in the washed bacteria (after resuspension and transfer to a fresh tube) using a gamma counter (model 1275; LKB Instruments, Inc., Gaithersburg, MD).
Measurement ofamino acid uptake. E. coli J5 (4 X 107/ml) were preincubated for 10 min in the presence of 100 sg/ml chloramphenicol at 37°C in the standard incubation medium. Human BPI was then added (time zero), and at the indicated time points, [3H]proline (20 MCi/ml final concentration) or '4C-mixed amino acids (4 ,Ci/ml final concentration) was added. After an additional 5-min incubation, the cells were filtered onto cellulose nitrate filters (0.45-mm pore size; Millipore Corp., Bedford, MA) and washed once with 5 ml of 0.8% (wt/vol) buffered nutrient broth. The radioactivity entrapped in the filter was measured by liquid scintillation counting (5) . To determine the amount of radioactivity binding nonspecifically to the bacteria and/or the filter, samples of E. coli were pretreated for 30 min with 10% formaldehyde before adding radioactive amino acids. These values were subtracted from all samples to calculate the actual uptake of amino acids.
Assay ofcytoplasmic membrane permeability. Cytoplasmic membrane permeability was monitored by measuring the hydrolysis of added ONPG at 37°C (0.5 mg/ml) by a strain of E. coli (ML-35) that contains cytoplasmic fl-galactosidase but is lactose-permease deficient (16) . Production of o-nitrophenol (ONP) was measured by determination of A4w. using a Beckman model DU-7 spectrophotometer after addition at various times of 500 !d of 20 mM NaOH to 250 ,d of the standard incubation mixture. Maximum rates of ONPG hydrolysis were obtained by disruption ofE. coli by sonication (4 X 15-s pulses on ice) using a micro-ultrasonic cell disrupter (Kontes Co., Vineland, NJ) at 75% of full strength.
Results
Dissociation ofthe bactericidal and permeability increasing effects ofBPI
The finding that the typically closely coupled effects of BPI on the E. coli envelope and growth (10) can be dissociated upon removal of > 80% of previously bound BPI by high concentrations of Mg2e (8, 9 ) prompted a search for additional means of exploring the relationship between the effects of BPI on the envelope and viability of E. coli. We have found that serum albumin provides a useful tool for the dissection of the sequential effects of BPI on E. coli. E. coli that is produced under our usual experimental conditions. In contrast, serum albumin even at 30-fold higher concentrations, does not prevent the permeability increasing effect of BPI (sensitivity to normally impermeant actD) (Table I) , nor the activation of the bacterial outer membrane phospholipase A (12) (not shown). Thus, these results demonstrate that the effects ofBPI on the envelope and on the viability ofE. coli can be completely, uncoupled. Although the potency of human BPI during incubation in nutrient broth increases with a drop in pH (Table II) , BSA is as effective at blocking the bactericidal activity of BPI at pH 6.0 as at 7.4 (Table I ). The ability of BSA to block growth inhibition at either pH 6.0 or 7.4 is not overcome by increasing the BPI dose (not shown). At doses corresponding to similar amounts of serum albumin added, heat treated (nonbactericidal) human serum, fatty acid and endotoxin free BSA, carboxymethylated BSA, BSA subjected to further purification by reverse phase HPLC, purified human serum albumin, and purified pig serum albumin (which lacks the N-terminal copper (Fig. 1) . Properties of BPI-treated E. coli during serum albuminmediated tolerance. The fact that serum albumin blocks bacterial killing without affecting either the initial binding or the outer envelope effects of BPI suggests that serum albumin renders the bacteria tolerant to the presence of BPI on the bacterial surface. To determine the duration of any sublethal effects exerted by BPI under these circumstances, we simultaneously monitored bacterial outer membrane permeability and growth during prolonged treatment of E. coli with BPI in the presence of serum albumin. BPI causes an almost immediate (< 1 min) breakdown ofthe outer membrane permeability barrier to actD that persists for up to 90 min (Fig. 2, top) . During this period, the optical density of the bacterial suspension increases in a time-dependent manner at a rate approximately half that of untreated bacteria (Fig. 2, middle) . In contrast, the number of colony forming units (CFU) during this same period does not increase (Fig. 2, bottom) . Examination of the BPI-treated E. coli by light microscopy (in a bacterial counting chamber) showed that during the first 90 min after addition of BPI, the bacteria grow without separation of the daughter cells, forming progressively longer chains (not shown). After -90 min incubation, the growth rate of the BPI-treated bacteria (as assessed by either optical density or CFU) shifts to that of the untreated bacteria, coincident with restoration ofthe outer membrane permeability barrier (Fig. 2 , compare upper panel with two lower panels) reflecting the emergence of an apparently normally growing bacterial population. However, this bacterial growth can only be sustained when serum albumin remains in the growth medium for at least 2.5 h. Subsequent plating in nutrient agar without serum albumin before this time results in arrest'of colony formation (Fig. 2 , bottom, solid circles, dotted line).
Rescue of BPI-pretreated E. coli by serum albumin. The preceding experiments indicate that serum albumin blocks event(s) required for killing by BPI that are distinct from the initial surface binding and outer envelope alterations. To determine when killing occurs, E. coli were incubated with supralethal doses of BPI for increasing'periods of time before addition of serum albumin and measurement of bacterial viability. BPI produces prompt arrest of bacterial growth during the preincubation without serum albumin both at pH 6.0 (Fig.   2 , middle panel) and at pH 7.4 (not shown). However, these treated bacteria can subsequently grow and form colonies upon addition of serum albumin (Fig. 3) despite the continued presence of BPI on the bacterial surface (Fig. 1) . The concentration of serum albumin required for rescue (serum albumin added after BPI) and for prevention of growth arrest (serum albumin added before BPI) is the same (compare Table III with Table I ). Moreover, the transient period of abnormal growth (chain formation) and actD sensitivity observed when serum albumin is added before BPI (Fig. 2) is also seen when BPI-pretreated E. coli are rescued by the subsequent addition indicated time points after BPI addition, aliquots were taken for measurement of: (a) bacterial outer membrane (OM) permeability (top) (b) absorbance at 550 nm after lOX dilution with saline (middle), and (c) bacterial viability (i.e., colony-forming ability) (bottom) as described in Methods. Samples containing BSA were plated on nutrient agar (solid circles, broken line), and on nutrient agar supplemented with 1 mg/ml BSA (solid circles, solid line). Virtually identical results were obtained when the incubation was carried out at pH 6.6 and pH 7.4 or when the BSA concentration was varied (range 200 ,g/ml to 5 mg/ml). Data represent the mean of at least 2 closely similar experiments. of serum albumin. Again, normal growth resumes after -90 min incubation with serum albumin, coincident with restoration of the outer membrane permeability barrier (not shown). Fig. 3 also shows that the number of BPI-pretreated bacteria that can be rescued by'serum albumin declines with increasing time ofpreincubation ofE. coli with human BPI. Loss of rescue occurs more rapidly at pH 6.0 (tj/2 = 10 min) than at pH 7.4 (t12 = 79 min) (Fig. 3 rather than human BPI (Table IV) , and identical results are obtained when heat-treated serum is used as a source of albumin. Inhibition of bacterial protein synthesis by pretreatment with chloramphenicol (100 gg/ml) also has no effect on the progression of BPI action from reversible to irreversible growth arrest (not shown). Similar rates of progression to serum albumin refractory growth inhibition are observed with several other strains of E. coli, including a strain bearing Kl capsule and a phospholipase-deficient (pldA-) mutant (14) that undergoes no phospholipid degradation during BPI treatment (Weiss, J., manuscript in preparation) (Table IV) . How- (Table IV) .
Irreversible growth arrest is accompanied byfunctional and structural damage to the cytoplasmic membrane. We have shown before that non-growing BPI-treated E. coli continue macromolecular synthesis (1-5, 7, 8) . Fig. 4 shows that the continued incorporation of mixed "'C-amino acids into protein by BPI-treated E. coli coincides with the serum albuminreversible phase of growth inhibition and that inhibition of amino acid incorporation occurs in a time-dependent fashion that parallels loss of rescue at both pH 7.4 (left) and pH 6.0 (right). However, amino acid incorporation appears to be inhibited before bacterial death (i.e., serum albumin refractory growth inhibition), analogous to the action of certain other cytotoxins (18, 19) ; this is more evident at pH 6.0 (Fig. 4,  right) . For example, after 10 min incubation at pH 6.0, amino acid incorporation is reduced to -10% of control levels although nearly 60% ofthe bacteria can still be rescued by serum albumin. Addition of serum albumin at this time point partially reverses the inhibition of amino acid incorporation as well, restoring protein synthesis to a level that matches the number of viable organisms (Fig. 4, right) . At later times (70 min), when growth inhibition has become irreversible, amino acid incorporation does not resume upon serum albumin addition (Fig. 4, right) . To determine whether the observed decrease in protein synthesis is due to a lesion in the protein biosynthetic machinery or secondary to a block in amino acid transport, uptake of 14C mixed amino acids into BPI-treated bacteria was measured. Table V shows that there is a sharp drop in net amino acid uptake within 5 min of BPI addition at pH 6.0, which parallels the observed drop in protein synthesis. Similar results are obtained when uptake is measured in the absence of chlor- To ascertain whether the observed loss of amino acid uptake is accompanied by direct cytoplasmic membrane damage, we assessed cytoplasmic membrane integrity by measuring the rate of hydrolysis of exogenously added ONPG to ONP after treatment of E. coli ML-35 with BPI. Because E. coli ML-35 lacks lactose-permease, (passive) permeation of ONPG across the cytoplasmic membrane is the rate-limiting step in its hydrolysis by cytoplasmic /3-galactosidase (16) . Fig. 5 shows that (Fig. 2, middle) , except for transient abnormal growth in chains. However, BPI binding ( Fig. 1 ) and the effects of BPI on the permeability barrier in the outer membrane (TableI, Fig. 2, top) and on bacterial phospholipolysis ( 12) are the same as without serum albumin. (b) Addition of serum albumin to the bacterial suspension at various times after BPI, or at the end of incubation to the culture medium, results in resumption of growth by gradually diminishing portions of the bacterial population that do not grow in the absence of serum albumin (Fig. 3) . This rescue takes place despite the fact that BPI remains bound to the bacterial surface (Fig. 1) and the envelope alterations persist (until the surviving population outgrows these effects). (c) The time course of decrease in the population of BPI-treated E. coli that can be rescued by serum albumin parallels the decrease in bacterial amino acid transport (Table V) and incorporation into protein (Fig. 4) . Further, Fig. 5 The rate of progression from reversible to irreversible growth inhibition in phosphate-buffered nutrient broth shows some strain to strain variation (Table IV) but in all cases is more rapid at pH 6.0 than at pH 7.4. Such a pH dependence of cytotoxicity is shared by several prokaryotic and eukaryotic toxins whose action depends on penetration across lipid bilayers as part of the target cell damage (27) (28) (29) (30) (31) (32) (33) (34) . We are now seeking evidence of penetration of a portion of bound BPI, or a biologically active fragment (12) further into the bacterial envelope. With these uncertainties in mind, we propose the working model of BPI actions depicted in Fig. 6 .
How serum albumin protects E. coli from the lethal effects of BPI without affecting BPI binding and the outer membrane alterations is not yet clear. A range of other neutral and acidic macromolecules at high concentrations does not affect BPI action indicating at least some specificity of the serum albumin effect (Table I) . Moreover, the effects of whole serum can be accounted for by its serum albumin content (Table I) , indi- cating that other serum constituents do not affect BPI action in a similar manner.
Although the broad complexing properties of serum albumin (35, 36) make it likely that any given preparation is contaminated with other substances, the same effects of multiple preparations of serum albumin, including those derived from coli (37) but have obtained no positive evidence of an additional serum albumin interaction with the BPI-coated envelope (unpublished observations). However, these negative findings do not exclude the possibility that weak interactions between BPI and serum albumin do prevent BPI from reaching sites involved in later (lethal) consequences of BPI-binding.
The fact that removal of serum albumin promptly re-establishes the growth inhibitory effects of the bound BPI (Fig. 1,   bottom) shows that rescue requires the continued presence of serum albumin and may support the notion of weak interactions. Detection of such a subtle action of serum albumin is difficult not only because the serum albumin effect is produced at a molar ratio of serum albumin/BPI > 100, but also because removal of> 85% of bound BPI by Mg2" or trypsin does not prevent killing, suggesting that the lethal effects of BPI are produced by a small portion (< 15%) of the total bound BPI with which serum albumin may be interacting.
Finally, while serum albumin has served to demonstrate that BPI actually is not a rapidly bactericidal agent, it is evident that BPI produces a virtually instantaneous bacteriostasis. Steps in BacterialKilling by a Neutrophil Cytotoxin 859
